A beat-plus-guidance-raise is the strongest earnings combination because analysts mechanically raise their forecasts afterward, which keeps buyers coming in for weeks — the classic post-earnings drift. Synopsys sits in the AI supply chain as the software

Verdict: strong franchise, deteriorating tape — wait for the MACD cross to fire

The strongest point for this idea is that the catalyst is confirmed: per the Yahoo Finance report of August 27, 2026, Synopsys beat Q3 forecasts and lifted fiscal 2026 guidance on strengthening AI demand, and cash generation backs it — quarterly free cash flow jumped 70% to $1.40B in the quarter ended April 30, 2026, while debt to equity has fallen every quarter since spiking to 1.01 in April 2025, reaching 0.33 by April 2026. The strongest point against is that reported economics are moving the wrong way fast: net income fell 73.7% quarter over quarter to $17.1M, net margin compressed to 0.75% from 2.70%, gross margin has declined for four straight quarters to 72.3%, and shares outstanding are up roughly 23% since October 2024 with no dividend to cushion holders. This setup is waiting on its entry conditions rather than on demonstrated past results — the MACD (12,26,9) line at -2.60 has not yet crossed above its signal, and price at $397.92 sits $22.48 below the 50-day EMA at $420.40 — so with two of the entry rules already met and a defined 2:1 reward-to-risk framework, the disciplined move is to wait for the trigger rather than buy an unconfirmed setup. The verdict flips if the next quarterly print (due early September 2026) shows margin stabilization, or if institutions show adding in a fresher ownership cycle than the thin June 30, 2026 snapshot of 6 holders with 2.51M shares.

Trade now

Synopsys closed at $397.92, which is below its 50-day EMA at $420.40 and just below the Bollinger (20) midpoint at $399.65, so two of the entry conditions are already met. The remaining live trigger is the MACD (12,26,9) line crossing above its signal line — MACD currently reads -2.60, so the cross has not happened yet. The rule set also requires a close back above the EMA, which is $22.48 away from the current price. In practice, that means the signal is a MACD cross followed by a close back above the 50-day EMA, which would confirm momentum turning. Once triggered, the risk framework is explicit: a hard stop at -2.47% (about $388.10 from the current close), a take-profit at +4.94% (about $417.56), plus a 61.8% Fibonacci retracement stop and a 127.2% extension target, with any position closed by force at 60 bars. That works out to roughly a 2:1 reward-to-risk before the Fibonacci levels. Position sizing is fixed-risk at 2.47% of equity, capped at 25% of the portfolio. What "wait" means concretely: do nothing until the MACD line crosses above its signal line on the daily chart, and ideally until price also reclaims the $420.40 EMA. Scope note: market-data coverage could not be verified within the analysis window, so no historical evaluation of this rule set was possible — the decision here rests on the live levels above, not on past performance figures.

The bull case: elite cash generation and a genuine beat-and-raise

The idea's core claim — that a beat plus a guidance raise triggers analyst upgrades and weeks of post-earnings drift — starts from a defensible catalyst. Per the Yahoo Finance report of August 27, 2026, Synopsys beat Q3 forecasts and lifted its fiscal 2026 guidance on strengthening AI demand, and the earnings call the prior evening leaned on that same theme. For a design-software franchise that sells picks and shovels into every AI chip program, a raised outlook is the kind of confirmatory signal that forecast revisions tend to chase. The fundamentals back the franchise quality. For fiscal 2025 (period ending October 31, 2025), Synopsys posted $7.05B of revenue, up 15.1% year…

Scores

• Conviction score breakdown: 48
• Thesis support: 62
• Trade readiness: 45
• Risk quality: 50
• Fundamentals trend: 35

Watch items

• SNPS — MACD (12,26,9) line vs signal line
• SNPS — Close vs 50-day EMA
• SNPS — Price vs fib 61.8% retracement
• SNPS — Net income (SEC XBRL)
• SNPS — 13F institutional ownership (filing for period ended 2026-06-30)
• SNPS — Revenue (SEC XBRL)
• SNPS — Price
• SNPS — Price
• SNPS — MACD (12,26,9) crossed above MACD (12,26,9)
• SNPS — Price above EMA (50)